ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 13151 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 13151; 2) Community: the network communities that were significantly associated with the response to NSC 13151; 3) Molecule: the relationships between components within communities and NSC 13151; 4) MDR: the compounds that were significantly associated with the NSC 13151.

NSC Compound Enrichment Correlation
NSC 639521 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-2-(phenylmethyl)-, hydrochloride 0.000385746291616526 0.53639937
NSC 666596 Null 0.000385746291616526 0.31751132
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.000385746291616526 0.38902366
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.000455867606843412 0.6106347
NSC 758682 ARTENIMOL 0.000455867606843412 0.49981048
NSC 718370 Null 0.000644707050513007 0.02636545
NSC 736163 pyrazoline derivative 0.000644707050513007 0.57364482
NSC 747825 3-(4-fluorophenyl)-8,9-dimethyl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl acetate 0.000644707050513007 0.44760784
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.000837923650101952 0.62525283
NSC 743244 Null 0.000837923650101952 0.59853289
Total:107  Current:3    [First] [Prev] [Next] [Last]